Laura Melado Vidales: High-Specific AMH Assays Refine Assessment of Low Ovarian Reserve
Laura Melado Vidales, Medical Director ART Fertility Clinics Abu Dhabi at ART Fertility Clinics, shared a post on LinkedIn about a paper published in Frontiers:
“Excited to share that our new paper is out in Frontiers in Endocrinology!
‘How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-Müllerian hormone with antral follicle count.’
Read here.
We show that combining high-specific AMH assays with antral follicle count (AFC) improves the prediction of ovarian response in women with low ovarian reserve, supporting more personalized fertility care.
Grateful to my co-authors and colleagues for this great collaboration!”
Title: How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count
Authors: Laura Melado, Ajay Kumar, Bhanu Kalra, Erkan Kalafat, Barbara Lawrenz, Human Fatemi
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
-
Dec 20, 2025, 10:53Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
-
Dec 20, 2025, 10:36Enhancing Care for Women Facing Recurrent Pregnancy Loss – SOGC
-
Dec 20, 2025, 05:00Ilana Ferhadian: Celebrating Book Launch
-
Dec 19, 2025, 16:21Launch of National Fertility Plan Marks Public Health Milestone – Collectif BAMP Association
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:16New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR